John David Gross

John David Gross

Auto-generated profile, based on publicly available information

John David Gross

Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in Nature
Verified
Journal Article
Closed access
PDF file
DGDavid E. Gordon
David E. Gordon
GJGwendolyn M. Jang
Gwendolyn M. Jang
MBMehdi Bouhaddou
Mehdi Bouhaddou
JXJiewei Xu
Jiewei Xu
KOKirsten Obernier
Kirsten Obernier
NKNevan J. Krogan
Nevan J. Krogan

16 October 2019 in Nature
Verified
Journal Article
Closed access
PDF file
SSS. Sanulli
S. Sanulli
MTM. J. Trnka
M. J. Trnka
VDV. Dharmarajan
V. Dharmarajan
RTR. W. Tibble
R. W. Tibble
BPB. D. Pascal
B. D. Pascal
GNG. J. Narlikar
G. J. Narlikar

21 December 2011 in Nature
Verified
Journal Article
Closed access
PDF file
SJStefanie Jäger
Stefanie Jäger
DKDong Young Kim
Dong Young Kim
JHJudd F. Hultquist
Judd F. Hultquist
KSKeisuke Shindo
Keisuke Shindo
RLRebecca S. LaRue
Rebecca S. LaRue
NKNevan J. Krogan
Nevan J. Krogan

22 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
GJGwendolyn M. Jang
Gwendolyn M. Jang
MBMehdi Bouhaddou
Mehdi Bouhaddou
JXJiewei Xu
Jiewei Xu
KOKirsten Obernier
Kirsten Obernier
MBMelanie Brewer
Melanie Brewer
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption 1,2 . There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 67 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.

5 December 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
JMJeffrey S. Mugridge
Jeffrey S. Mugridge
JCJeff Coller
Jeff Coller
JGJohn D. Gross
John D. Gross

20 January 2017 in Science
Verified
Journal Article
Closed access
PDF file
KSKalyan K. Sinha
Kalyan K. Sinha
JGJohn D. Gross
John D. Gross
GNGeeta J. Narlikar
Geeta J. Narlikar
Deformation powers the nucleosome slide: In eukaryotes, DNA is packed onto nucleosomes. For transcription factors and other proteins to gain access to DNA, nucleosomes must be moved out of the way, or “remodeled”—but not disassembled. Nucleosomes are composed of histone protein octamers, the cores of which have generally been considered to be fairly rigid. Sinha et al. used nuclear magnetic resonance and protein cross-linking to show that one of the enzyme complexes that remodel nucleosomes, SNF2h, is able to distort the histone octamer (see the Perspective by Flaus and Owen-Hughes). Nucleosome deformation was important for this remodeler to be able to slide nucleosomes out of the way. Science , this issue p. 10.1126/science.aaa3761 ; see also p. 245